Abstract
CoA-independent transacylase activities generating alkylacylglycerophosphocholine (AAGPC) from alkylglycerophosphocholine (1-alkyl GPC) were considerably enriched in neuronal nuclei isolated from rabbit cerebral cortex. Specific nuclear transacylation activities were 13 times the corresponding microsomal values. Several lysophospholipids, notably 1-acyl glycerophosphocholine (1-acyl GPC), 1-alkenyl GPC and 1-alkenyl GPE (1-alkenyl glycerophosphoethanolamine) inhibited the transacylation of 1-alkyl GPC. The inhibitory effects of 1-acyl GPC were seen in the presence of MAFP (methyl arachidonoylfluorophosphonate) or free oleate, compounds that inhibit neuronal nuclear lysophospholipase. When neuronal nuclei were preincubated with 1-alkyl GPC, the radioactive AAGPC product served as donor in transacylation reactions, to generate 1-alkyl GPC. In these nuclear reactions, 1-palmitoyl GPE and 1-palmitoyl GPC appeared to be poor acceptor substrates, when compared with corresponding 1-alkyl and 1-alkenyl analogues. The presence of free oleate or MAFP in the reactions containing 1-acyl GPC boosted the release of 1-alkyl GPC from AAGPC. These observations are of particular relevance to brain ischemia in which lysophospholipid, free fatty acid, and platelet-activating factor (PAF) levels rise dramatically. PAF can be made by the nuclear acetylation of 1-alkyl GPC, which is formed by nuclear transacylation mechanisms. Yet transacylase also removes 1-alkyl GPC, and thus this enzyme activity can regulate 1-alkyl GPC availability. Our observations indicate that lysophospholipids promote the formation of 1-alkyl GPC from nuclear AAGPC via transacylation, while free fatty acid likely prolongs the lifetime of 1-acyl lysophospholipids substrates by lysophospholipase inhibition. Similarly, once 1-alkyl GPC is formed, other lysophospholipids effectively compete with this 1-alkyl analogue and reduce its conversion back to AAGPC by transacylation. Free oleate, in this case, sustains 1-acyl lysophospholipid inhibitors of 1-alkyl GPC transacylation. Thus the cycle of transacylation may favour 1-alkyl GPC formation during ischemia, increasing levels of 1-alkyl GPC for nuclear acetylation reactions and PAF formation. The nuclear generation of PAF is of considerable importance as PAF can play regulatory roles in transcription events associated with inflammation.
Similar content being viewed by others
References
Baker RR, Chang Hy: Alkylglycerophosphate acetyltransferase and lyso platelet activating factor acetyltransferase, two key enzymes in the synthesis of platelet activating factor, are found in neuronal nuclei isolated from cerebral cortex. Biochim Biophys Acta 1302:257–263, 1996
Lukiw WJ, Palacios Pelaez R, Martinez J, Bazan NG: Budesonide epimer R or dexamathasone selectively inhibit platelet-activating factor-induced or interleukin 1β-induced DNA biding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. Proc Natl Acad Sci USA 95:3914–3919, 1998
Bazan NG: Inflammation: A signal terminator. Nature 374: 501–502, 1995
Snyder F: Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim Biophys Acta 1254:231–249, 1995
Venable ME, Nieto M, Schmitt JD, Wykle RL: Conversion of 1-O-[3H] alkyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine to lyso platelet-activating factor by the CoA-independent transacylase in membrane fractions of human neutrophils. J Biol Chem 266: 18691–18698, 1991
Uemura Y, Lee Tc, Snyder F: A Coenzyme A-independent transacylase is linked to the formation of platelet-activating factor (PAF) by generating the lyso-PAF intermediate in the remodelling pathway. J Biol Chem 266: 8268–8271, 1991
Kramer RM, Deykin D: Arachidonoyl transacylase in human platelets: Coenzyme A-independent transfer of arachidonate from phosphatidylcholine to lysoplasmenylethanolamine. J Biol Chem 258: 13806–13811, 1983
Kramer RM, Patton GM, Prizker CR, Deykin D: Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. J Biol Chem 259: 13316–13320, 1984
Snyder F, Lee TC, Blank ML: The role of transacylases in the metabolism of arachidonate and platelet-activating factor. Prog Lipid Res 31: 65–82, 1992
Ojima A, Nakagawa Y, Sugiura T, Masuzawa Y, Waku K: Selective transacylation of 1-O-alkylglycerophosphoethanolamine by docosahexaenaote and arachidonate in rat brain microsomes. J Neurochem 48: 1403–1410, 1987
Masuzawa Y, Sugiura T, Sprecher H, Waku K: Selective acyl transfer in the reacylation of brain glycerophospholipids. Comparison of three acylation systems for 1-alk-1'-enylglycero-3-phosphoethanolamine, 1-acylglycero-3-phosphoethanolamine and 1-acylglycero-3-phosphocholine in rat brain microsomes. Biochim Biophys Acta 1005: 1–12, 1989
Erbland J, Marinetti GV: The metabolism of lysolecithin in rat liver particulate systems. Biochim Biophys Acta 106: 139–144, 1965
Blank ML, Fitzgerald V, Smith ZL, Snyder F: Generation of the precursor (lyso-PAF) of platelet-activating factor via CoA-dependent transacylase. Biochem Biophys Res Commun 210: 1052–1058, 1995
Yamashita A, Sugiura T, Waku K: Acyltransferases and transacylases involved in fatty acid remodelling of phospholipids and metabolism of bioactive lipids in mammalian cells. J Biochem 122: 1–16, 1997
Sugiura T, Masuzawa Y, Nakagawa Y, Waku K: Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes: Distinct donor and acceptor selectivities. J Biol Chem 262: 1199–1205, 1987
Nixon AB, Greene DG, Wykle RL: Comparison of acceptor and donor substrates in the CoA-independent transacylase reaction in human neutrophils. Biochim Biophys Acta 1300: 187–196, 1996
Surette MC, Chilton FH: The distribution and metabolism of arachidonate-containing phospholipids in cellular nuclei. Biochem J 330: 915–921, 1998
Domingo MT, Spinnewyn B, Chabrier PE, Braquet P: Changes in [3H] PAF binding and PAF concentration in gerbil brain after bilateral common artery occlusion: A quantitative autoradiographic study. Brain Res 640: 268–276, 1994
Lindsberg PJ, Yue TL, Frerichs KU, Hallenbeck JM, Feuerstein G: Evidence of platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 21: 14520–14527, 1990
Pettigrew LC, Meyer JJ, Craddock SD, Butler SM, Tai HH, Yokel RA: Delayed elevation of platelet-activating factor in ischemic hippocampus. Brain Res 691: 243–247, 1995
Sun, GY, Foudin LL: On the status of lysolecithin in rat cerebral cortex during ischemia. J Neurochem 43: 1081–1086, 1984
Moto A, Hirashima Y, Endo S, Takaku A: Changes in lipid metabolites and enzymes in rat brain due to ischemia and recirculation. Mol Chem Neuropathol 14: 35–51, 1991
Bazan NG: Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218: 1–10, 1970
Ljunggren B, Schutz H, Siesjo BK: Changes in energy state and acidbase parameters in rat brain during complete compression ischemia. Brain Res 73: 277–289, 1974
Baker RR, Chang Hy: MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities. Biochim Acta 1392: 351–360, 1998
Baker RR, Chang Hy: Evidence for two distinct lysophospholipase activities that degrade lysophosphatidylcholine and lysophosphatidic acid in neuronal nuclei of cerebral cortex. Biochim Biophys Acta 1438: 253–263, 1999
Baker RR, Chang Hy: Lysophosphatidic acid, alkylglycerophosphate and alkylacetylglycerophosphate increase the neuronal nuclear acetylation of 1-acyl lysophosphatidylcholine by inhibition of lysophospholipase. Mol Cell Biochem 198: 47–55, 1999
Ravandi A, Kuksis A, Jackowski G: Preparation of schiff base adducts of phosphatidylcholine core aldehydes and aminophospholipids, amino acids and myoglobin. Lipids 32: 989–1001, 1997
Thompson RJ: Studies on RNA synthesis in two populations of nuclei isolated from the mammalian cerebral cortex. J Neurochem 21: 19–40, 1973
Baker RR, Chang Hy: The fatty acid composition of lipids of neuronal and glial nuclear fractions isolated from 15-day-old rabbit cerebral cortex. Can J Biochem 58: 620–628, 1980
Bartlett G: Phosphorus assay in column chromatography. J Biol Chem 234: 466–468, 1959
Kates M: Techniques of Lipidology. In: T.S. Work, E. Work (eds). Laboratory Techniques in Biochemistry and Molecular Biology. American Elsevier, New York, 1975, p 569
Blank ML, Smith ZL, Fitzgerald V, Snyder F: The CoA-independent transacylase in PAF biosynthesis: Tissue distribution and molecular species selectivity. Biochim Biophys Acta 1254: 295–301, 1995
Baker RR, Chang Hy: A comparison of lysophosphatidylcholine acyltransferase activities in neuronal nuclei and microsomes isolated from immature rabbit cerebral cortex. Biochim Biophys Acta 666: 223–229, 1981
Wykle RL, Schremmer JM: A lysophospholipase D pathway in the metabolism of ether-linked lipids in brain. J Biol Chem 249: 1742–1746, 1974
Baker RR, Chang Hy: Cholinephosphotransferase activities in microsomes and neuronal nuclei isolated from immature rabbit cerebral cortex: The use of endogenously generated diacylglycerols as substrate. Can J Biochem 60: 724–733, 1980
Lio YC, Dennis EA: Interfacial activation, lysophospholipase and transacylase activity of Group VI Ca2+-independent phospholipase A2. Biochim Biophys Acta 1392: 320–332, 1998
Balsinde J, Dennis EA: Distinct roles in signal transduction for each of the phospholipase A2 enzymes present in P388D1 macrophages. J Biol Chem 271: 6758–6765, 1996
Yoshida S, Inoh, S, Asano T, Sano, K, Shimasaki H, Ueta N: Brain free fatty acids, edema and mortality in gerbils subjected to transient, bilateral ischemia, and effect of barbiturate anesthesia. J Neurochem 40: 1278–1286, 1983
Katsura Ki, Rodriguez de Turco EB, Folbergrova J, Bazan NG, Siesjo BK: Coupling among energy failure, loss of ion homeostasis, and phospholipase A2 and C activation during ischemia. J Neurochem 61: 1677–1684, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baker, R.R., Chang, HY. The regulation of CoA-independent transacylation reactions in neuronal nuclei by lysophospholipid, free fatty acid, and lysophospholipase: The control of nuclear lyso platelet-activating factor metabolism. Mol Cell Biochem 215, 135–144 (2000). https://doi.org/10.1023/A:1026535611654
Issue Date:
DOI: https://doi.org/10.1023/A:1026535611654